1. Home
  2. YQ vs CTSO Comparison

YQ vs CTSO Comparison

Compare YQ & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YQ

17 Education & Technology Group Inc.

N/A

Current Price

$3.39

Market Cap

22.2M

Sector

Real Estate

ML Signal

N/A

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

N/A

Current Price

$6.12

Market Cap

23.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YQ
CTSO
Founded
2012
1997
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.2M
23.9M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
YQ
CTSO
Price
$3.39
$6.12
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
70.8K
382.2K
Earning Date
06-09-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.79
EPS
N/A
N/A
Revenue
N/A
$22,503,908.00
Revenue This Year
N/A
$10.34
Revenue Next Year
N/A
$22.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.53
52 Week Low
$1.68
$0.30
52 Week High
$6.45
$7.44

Technical Indicators

Market Signals
Indicator
YQ
CTSO
Relative Strength Index (RSI) 57.25 85.38
Support Level $3.28 $0.48
Resistance Level $3.68 $7.44
Average True Range (ATR) 0.44 0.30
MACD 0.12 0.61
Stochastic Oscillator 53.56 80.64

Price Performance

Historical Comparison
YQ
CTSO

About YQ 17 Education & Technology Group Inc.

17 Education & Technology Group Inc is engaged in providing education and education technology services in the People's Republic of China (PRC) with a focus on the Teaching and Learning SaaS offerings. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: